Dendrimer-driven neurotrophin expression differs in temporal patterns between rodent and human stem cells

Area of Science:

• Biotechnology
• Stem Cell Biology
• Neuroscience

Background:

• Viral vectors pose risks for long-term neurotrophin expression.
• Nonviral methods offer a safer alternative for gene delivery.
• Polyamidoamine dendrimers are effective nonviral gene delivery agents.

Purpose of the Study:

• To evaluate nonviral, time-restricted neurotrophin overproduction using polyamidoamine dendrimers.
• To compare neurotrophin expression timelines in different stem cell types (mesenchymal stem cells and Schwann cells).
• To assess dendrimer-based gene delivery for brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3).

Main Methods:

• Utilized polyamidoamine dendrimers for nonviral plasmid delivery.
• Transfected rodent and human mesenchymal stem cells and Schwann cells with BDNF or NT-3 plasmids.
• Monitored transfection efficiency, protein expression levels, and expression timelines.

Main Results:

• Comparable transfection efficiencies and protein expression levels were observed between cell types.
• Dendrimer-driven neurotrophin expression declined more rapidly in human mesenchymal stem cells than in rodent cells.
• Nonviral delivery demonstrated biologically safe and accessible neurotrophin expression.

Conclusions:

• Nonviral dendrimer systems provide time-restricted neurotrophin expression in stem cells.
• Differences in expression kinetics between human and rodent cells warrant further investigation.
• This approach enhances the therapeutic potential of stem cells for regenerative medicine.